Table 3 Appropriate monitoring of Noninvasive Respiratory Support (NIRS)
From: Noninvasive respiratory support for COVID-19 patients: when, for whom, and how?
Appropriate Monitoring of Noninvasive Respiratory Support |
1) Hourly lab assessment (for 3 h)   a) ABG including PaO2, PaCO2, bicarbonate, lactate, and base excess   b) PaO2/FiO2 (target PaO2/FiO2 > 300) [24, 50]   c) Subjective improvement or worsening of dyspnea [4] 2) Continuous monitoring (for 3 h):   a) Heart rate and respiratory rate trends [4, 24]   b) Pulse oximetry and FiO2 requirement   c) Tidal volume measurement if utilizing CPAP or NIV [21, 43, 54] |